KULR Technology Group, Inc. misses Q1 expectations, remains overvalued, and faces challenges in new ventures. Click for my ...

Optimized treatment reduces the mortality risk associated with chronic heart failure, leading to improvements in both ...

The results of an international study led by researchers from Queen Mary University of London’s Precision Healthcare University Research Institute (PHURI) shed new light the underlying biological ...

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are ...

IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its first ...

Kim Haberly’s dark blonde hair hangs behind her shoulders away from her face. Her almond-shaped eyes are faintly ringed by ...

The study, carried out in collaboration with the Berlin Institute of Health at Charité (BIH), and the Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge, was published ...

This New Berlin boy's routine tonsil surgery led to 54 days in the hospital with at least 6 other surgeries and multiple complications. His family still doesn't know when he will be able to come home.

HOUSTON, May 15, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a ...